UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                          _____________________________

                                    FORM 8-K


                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934
                          _____________________________

        Date of Report (Date of earliest event reported): April 24, 2003

                           Orthofix International N.V.
             (Exact name of Registrant as specified in its charter)

    Netherlands Antilles                 0-19961                  N/A
(State or other jurisdiction     Commission File Number   (I.R.S. Employer
     of incorporation)                                  Identification Number)
                          _____________________________

                             7 Abraham de Veerstraat
                                     Curacao
                              Netherlands Antilles
                               011-59-99-465-8525
                  (Address of principal executive offices and
                     telephone number, including area code)
                          _____________________________



Item 9. Regulation FD Disclosure (and information furnished under Item 12).

     The following information is furnished pursuant to Item 9, "Regulation FD
Disclosure" and Item 12, "Results of Operations and Financial Condition." On
April 24, 2003, Orthofix International N.V. ("Orthofix") issued a press release
announcing, among other things, its results of operations for the quarter ended
March 31, 2003. A copy of the press release is attached hereto as Exhibit 99.1
and is incorporated by reference herein.

     In addition, Orthofix announced in its press release dated April 24, 2003
that, excluding litigation costs of $0.9 million related to KCI patent
infringement case, net income for the first quarter ended March 31, 2003 would
have been $6.8 million, or $0.47 per share. Orthofix believes that this net
income measure, excluding KCI litigation costs, is a useful proxy for Orthofix's
results from operations because Orthofix did not incur any KCI related
litigation costs in the first quarter of 2002.




     Exhibit

     99.1 Press release of Orthofix International N.V. dated April 24, 2003






                                    Signature



     Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

Dated: April 25, 2003

                                    ORTHOFIX INTERNATIONAL N.V.


                                    By: /s/ THOMAS HEIN
                                        -----------------------------------
                                           Name:  Thomas Hein
                                           Title: Chief Financial Officer